Ianalumab add-on therapy in CLL patients receiving ibrutinib

(1:47)

Phase Ib trial of ianalumab plus ibrutinib for CLL

(4:8)

Phase Ib trial of ianalumab and ibrutinib in CLL

(3:51)

Subcutaneous ianalumab safe and effective for Sjögren's syndrome

(1:14)

Phase Ib trial of ianalumab plus ibrutinib for CLL

(4:43)

A Day In My Life With Severe Fatigue | Chronic Illness | Sjogrens, Dysautonomia, Fibromyalgia

(14:18)

What has changed in ITP over the last 20 years Professor David Kuter

(26:22)

Dazodalibep: A Glimmer of Hope in Sjogren's Syndrome?

(6:39)

Ian \u0026 Diana Bruce - Fluorite Mining from 2017 - TFMG 2024 Speaker Series

(1:3:32)

Medication Adherence \u0026 Smart Devices for Clinical Trials by Ypsomed, Philips, \u0026 AWS

(1:33)

Continuous Improvement in Pharmaceutical Manufacturing - An ICH Q10 Perspective

(18:1econd)

Treating Diabetes: Heart Smart Benefits

(52:30)

The Rise of B-Cell Therapies in Relapsing MS

(1:3:27)

Care Connection Webinar: Medications and Your Memory

(58:22)

Novartis Strategy \u0026 Growth Update

(20:35)

Adding a Monoclonal Antibody to Ibrutinib Therapy for CLL - Dr. Kerry Rogers ASH 2021

(10:32)

Novartis Phase III CT Protocol For Lanalumab Rejected By CDSCO Panel

(1:24)

SLE Panel Review - EULAR 2023

(32:30)

CLL: Do Anti CD20 Monoclonal Antibodies Add to Novel Agent Outcomes?

(18:20)

Remibrutinib in Sjogren's Syndrome

(1:40)

Nick has high cholesterol

(31)

The ALTITUDE-AD trial: targeting soluble amyloid-β oligomers with sabirnetug in AD

(1:43)

For You 60 second commercial

(1:1econd)

Preview: Beyond the Ads: New Insulin Formulations and Diabetes Drug Updates for 2017

(49)

Medications: Add New

(7:46)

MacLaine's Asthma product ad

(54)

AsthmaMan for AstraZeneca

(32)

The optimization of induction chemotherapy for patients with AML

(3:16)

AsthmaMan for AstraZeneca

(33)